Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BMC128
i
Other names:
BMC128, BMC-128, BMC 128
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Evogene
Drug class:
Microbiome modulator
Related drugs:
‹
ART12 (1)
CJRB-101 (0)
CBM588 (0)
EDP1503 (0)
GB104 (0)
MaaT013 (0)
MaaT033 (0)
RBX7455 intratumoral (0)
ART12 (1)
CJRB-101 (0)
CBM588 (0)
EDP1503 (0)
GB104 (0)
MaaT013 (0)
MaaT033 (0)
RBX7455 intratumoral (0)
›
Associations
News
Trials
Filter by
Latest
10ms
BMC128-001: A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 (clinicaltrials.gov)
P1, N=12, Active, not recruiting, Biomica Ltd. | Recruiting --> Active, not recruiting
10 months ago
Enrollment closed
|
EGFR wild-type • ALK wild-type
|
Opdivo (nivolumab) • BMC128
over1year
BMC128-001: A First-in-human (FIH) Combination Treatment Study With a Single Dose Level of BMC128 (clinicaltrials.gov)
P1, N=12, Recruiting, Biomica Ltd. | Trial completion date: May 2023 --> Nov 2025 | Trial primary completion date: Feb 2023 --> Apr 2024
over 1 year ago
Trial completion date • Trial primary completion date • Combination therapy
|
EGFR wild-type • ALK wild-type
|
Opdivo (nivolumab) • BMC128
Share via
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login